Determinants of influenza and pneumococcal vaccination in patients with chronic lung diseases

Journal of Infection

Volumn 55, Issue 4, 2007, Pages 347-352

  Schoefer, Yvonne ^a,b   Schaberg, Tom ^c   Raspe, Heiner ^a   Schaefer, Torsten ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Center of Respiratory Medicine   (Germany)

Author keywords

Chronic lung diseases; Influenza vaccination; Pneumococcal vaccination

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASTHMA; BIVARIATE ANALYSIS; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; GERMANY; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; QUESTIONNAIRE; STREPTOCOCCUS INFECTION; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; FEMALE; GERMANY; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VACCINATION;

EID: 34548534467     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.06.002     Document Type: Article

References (45)

1. Fedson D.S. Adult immunization. Summary of the National Vaccine Advisory Committee Report. JAMA 272 (1994) 1133-1137
2. Gardner P., and Schaffner W. Immunization of adults. N Engl J Med 328 (1993) 1252-1258
3. Robert Koch Institut. Empfehlungen der ständigen Impfkommission (STIKO) am Robert Koch Institut. Epidemiol Bull 30 (2006) 235-254
4. Robert Koch Institut. Efficacy and safety of influenza and pneumococcal vaccinations in patients with chronic lung diseases. Comments Epidemiol Bull (2004) 1-5. http://www.rki.de/cln_049/nn_195846/DE/Content/Infekt/Impfen/STIKO__Empf ehlungen/Begruendung/begruendung__node.html?__nnn=true
5. Lee T.A., Weaver F.M., and Weiss K.B. Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma. J Gen Intern Med 22 (2007) 62-67
6. Alfageme I., Vazquez R., Reyes N., Munoz J., Fernandez A., Hernandez M., et al. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax 61 (2006) 189-195
7. Christenson B., Lundbergh P., Hedlund J., and Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 357 (2001) 1008-1011
8. Cornu C., Yzebe D., Leophonte P., Gaillat J., Boissel J.P., and Cucherat M. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 19 (2001) 4780-4790
9. Jefferson T., Rivetti D., Di Pietrantonj C., Rivetti A., and Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev (2007) CD001269
10. Rivetti D., Jefferson T., Thomas R., Rudin M., Rivetti A., Di Pietrantonj C., et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 3 (2006) CD004876
11. Dear K., Holden J., Andrews R., and Tatham D. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev (2003) CD000422
12. Wiese-Posselt M., Leitmeyer K., Hamouda O., Bocter N., Zollner I., Haas W., et al. Influenza vaccination coverage in adults belonging to defined target groups, Germany, 2003/2004. Vaccine (2005)
13. Chi R.C., and Neuzil K.M. The association of sociodemographic factors and patient attitudes on influenza vaccination rates in older persons. Am J Med Sci 327 (2004) 113-117
14. Christenson B., and Lundbergh P. Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection. Epidemiol Infect 129 (2002) 515-524
15. D'Argenio P., Adamo B., Coluccio R., D'Apice A., Ferrara M.A., Giugliano F., et al. Influenza vaccination coverage in elderly people, Campania (Italy), 1999. Euro Surveill 6 (2001) 26-30
16. Ehresmann K.R., Ramesh A., Como-Sabetti K., Peterson D.C., Whitney C.G., and Moore K.A. Factors associated with self-reported pneumococcal immunization among adults 65 years of age or older in the Minneapolis-St. Paul metropolitan area. Prev Med 32 (2001) 409-415
17. Evans M.R., and Watson P.A. Why do older people not get immunised against influenza? A community survey. Vaccine 21 (2003) 2421-2427
18. Kaufman Z., and Green M.S. Compliance with influenza and pneumococcal vaccinations in Israel, 1999-2002. Public Health Rev 31 (2003) 71-79
19. Kroneman M.W., van Essen G.A., Tacken M.A., Paget W.J., and Verheij R. Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands. Vaccine 22 (2004) 2163-2170
20. Nowalk M.P., Zimmerman R.K., Shen S., Jewell I.K., and Raymund M. Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000-2001). J Am Geriatr Soc 52 (2004) 25-30
21. Rehmet S., Ammon A., Pfaff G., Bocter N., and Petersen L.R. Cross-sectional study on influenza vaccination, Germany, 1999-2000. Emerg Infect Dis 8 (2002) 1442-1447
22. Santibanez T.A., Nowalk M.P., Zimmerman R.K., Jewell I.K., Bardella I.J., Wilson S.A., et al. Knowledge and beliefs about influenza, pneumococcal disease, and immunizations among older people. J Am Geriatr Soc 50 (2002) 1711-1716
23. Wilson D., Lester R., Taylor A., Gill T., Dal Grande E., Litt J., et al. Prevalence of influenza immunisation in Australia and suggestions for future targeting of campaigns. Soz Praventivmed 47 (2002) 91-99
24. Jimenez-Garcia R., Arinez-Fernandez M.C., Hernandez-Barrera V., Garcia-Carballo M.M., de Miguel A.G., and Carrasco-Garrido P. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain. J Infect 54 (2007) 65-74
25. Arinez-Fernandez M.C., Carrasco-Garrido P., Garcia-Carballo M., Hernandez-Barrera V., de Miguel A.G., and Jimenez-Garcia R. Determinants of pneumococcal vaccination among patients with chronic obstructive pulmonary disease in Spain. Hum Vaccin 2 (2006) 99-104
26. Mayo M.E., Hernandez-Barrera V., Carrasco-Garrido P., Gil d.M., and Jimenez-Garcia R. Influenza vaccination among persons with chronic respiratory diseases: Coverage, related factors and time-trend, 1993-2001. Public Health 121 (2007) 113-121
27. Kroneman M., van Essen G.A., and John P.W. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine 24 (2006) 622-628
28. Nowalk M.P., Zimmerman R.K., Tabbarah M., Raymund M., and Jewell I.K. Determinants of adult vaccination at inner-city health centers: a descriptive study. BMC Fam Pract 7 (2006) 2
29. Petersen R.L., Saag K., Wallace R.B., and Doebbeling B.N. Influenza and pneumococcal vaccine receipt in older persons with chronic disease: a population-based study. Med Care 37 (1999) 502-509
30. Nichol K.L., and Zimmerman R. Generalist and subspecialist physicians' knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a nationwide survey. Arch Intern Med 161 (2001) 2702-2708
31. Szilagyi P.G., Shone L.P., Barth R., Kouides R.W., Long C., Humiston S.G., et al. Physician practices and attitudes regarding adult immunizations. Prev Med 40 (2005) 152-161
32. Luthi J.C., Mean F., Ammon C., and Burnand B. Evaluation of a population-based prevention program against influenza among Swiss elderly people. Swiss Med Wkly 132 (2002) 592-597
33. Kroneman M., Paget W.J., and van Essen G.A. Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake. Euro Surveill 8 (2003) 130-138
34. Ambrosch F., and Fedson D.S. Influenza vaccination in 29 countries. An update to 1997. Pharmacoeconomics 16 Suppl. 1 (1999) 47-54
35. Fedson D.S., Hannoun C., Leese J., Sprenger M.J., Hampson A.W., Bro-Jorgensen K., et al. Influenza vaccination in 18 developed countries, 1980-1992. Vaccine 13 (1995) 623-627
36. Nguyen-Van-Tam J.S., and Neal K.R. Clinical effectiveness, policies, and practices for influenza and pneumococcal vaccines. Semin Respir Infect 14 (1999) 184-195
37. Bridges C.B., Winquist A.G., Fukuda K., Cox N.J., Singleton J.A., and Strikas R.A. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 49 (2000) 1-38
38. Zimmerman R.K. Lowering the age for routine influenza vaccination to 50 years: AAFP leads the nation in influenza vaccine policy. American Academy of Family Physicians. Am Fam Physician 60 (1999) 2061-2070
39. Tata L.J., West J., Harrison T., Farrington P., Smith C., and Hubbard R. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?. Thorax 58 (2003) 835-839
40. Horwood F., and Macfarlane J. Pneumococcal and influenza vaccination: current situation and future prospects. Thorax 57 Suppl. 2 (2002) II24-II30
41. van der Wouden J.C., Bueving H.J., and Poole P. Preventing influenza: An overview of systematic reviews. Respir Med 99 (2005) 1341-1349
42. Christenson B., Hedlund J., Lundbergh P., and Ortqvist A. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 23 (2004) 363-368
43. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., and Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 348 (2003) 1322-1332
44. Watson L., Wilson B.J., and Waugh N. Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults. Vaccine 20 (2002) 2166-2173
45. Klugman K.P., and Madhi S.A. Pneumococcal vaccines and flu preparedness. Science 316 (2007) 49-50